Essity B 288.4 (-0.9 SEK) on 01-Jun-2023 17:29
Select region

Global Site

USA USA Russia Russia Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain

Did you mean

    Advanced search

    Quick results

    View all results

    These might help

    Corporate press releases

    Corporate News

    Investor Relations Calendar

    Essity logo
    Brands

    Company

    We are a global, leading hygiene and health company

    Explore Company

    Essity at a Glance
    Purpose and Vision Our Beliefs Our History
    Business Areas
    Health & Medical Consumer Goods Professional Hygiene Market and Trends E-Commerce
    Breaking Barriers to Well-being
    Stories Partnerships Insights Events Articles
    Strategy
    Our Business Model Our Strategic Priorities
    Organization and Management
    Board of Directors Executive Management Team
    Corporate Governance
    Articles of Association General Meeting Nomination Committee Auditors Board and Committee Work Remuneration to the Board of Directors Remuneration Policy Public Policies
    Essity in the World

    Brands

    Brands

    Sustainability

    We are committed to improving the well-being of people and planet

    Explore Sustainability

    Improving well-being for people and societies
    Hygiene and Health Diversity, Equity and Inclusion Business Ethics and Human Rights Occupational health and safety Product safety and transparency
    Reducing our environmental impact on the planet
    Forest and Fiber Emissions Plastics Waste Water
    Sustainability reporting, governance and data
    Essity’s Sustainability Publications Sustainability Governance Ratings and Recognitions Certifications
    Role in Society
    Partnerships and Collaborations Essity in the Spotlight Ways of Working Trade Associations and Policy Organizations Public Policy Development Positions Advancing the Knowledge
    Contact Us

    Innovation

    Innovation is deeply embedded in our company’s strategy and business model

    Explore Innovations

    Products and Solutions
    Digitalization
    Essity Ventures
    Latest Innovations

    Careers

    Careers

    Job Opportunities
    Work at Essity
    Commitment to Our Employees Diversity, Equity and Inclusion Learning and Development Why Choose Essity? Barrier Breakers
    Students and Graduates
    Graduates Students Internships Apprenticeships
    Life at Essity
    Women in Technology Making HerStory Career Stories
    Alumni Network
    Connect with Us
    Listen to us
    Total Rewards

    Investors

    We are a global, leading hygiene and health company

    Explore Investor

    Essity as an Investment
    Targets and Outcomes
    Essity Share
    Data per Share Ownership Dividend List of Analysts Trade Information Share Conversion Share Capital Development Indexes
    Financials
    Reports
    Interim Reports Annual Reports Prospectus
    Presentations and Webcasts
    Business Area Web Presentations
    Capital Markets Day 2021
    Investor Day 2019
    Debt Financing
    Debt Programmes Credit Rating Funding Sources Key Debt Ratios
    Essity Data
    Acquisitions and Divestments
    Investor Relations Calendar
    Investor Relations Contacts
    Subscribe

    Media

    Explore Press Center

    Press Releases
    News Features
    Images & Video
    Subscribe
    Media Contact
    Local Media Contacts
    Essity in Social Media
    Home
    Media
    Press releases
    2023
    Media
    Press Releases News Features Images & Video Subscribe Media Contact Essity in Social Media

    April 26, 2023

    Essity initiates a strategic review of its ownership of Vinda and the Consumer Tissue Private Label Europe business

    The hygiene and health company Essity has decided to initiate a strategic review of the company’s ownership of the Asian hygiene company Vinda International Holdings Ltd (Vinda) and the Consumer Tissue Private Label Europe business with the aim of reducing Consumer Tissue’s share of the company’s total sales.

    Essity continuously evaluates the product portfolios within the company’s three business areas, Health & Medical, Consumer Goods and Professional Hygiene, to achieve increased long-term value creation. In line with this, Essity is initiating a strategic review of the company’s ownership of Vinda and the Consumer Tissue Private Label Europe business. The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken.

    Essity’s net sales for 2022 amounted to approximately SEK 156bn, of which Vinda accounted for approximately 16% and the Consumer Tissue Private Label Europe business approximately 6%. Vinda and the Consumer Tissue Private Label Europe business accounted for approximately 34% of the business area Consumer Goods net sales 2022 and approximately 45% of the Consumer Tissue category net sales in 2022.

    Essity’s ownership in Vinda amounts to 51.59% and Essity consolidates 100%. Vinda is listed on the Hong Kong Stock Exchange and had a market capitalization of approximately HKD 26bn (approximately SEK 34bn) at the end of trading on April 25, 2023. Vinda’s net sales in 2022 amounted to approximately SEK 25.1bn and EBITA amounted to approximately SEK 1.1bn. Of Vinda’s net sales, 83% were related to tissue and 17% were related to personal care.

    Net sales for the Consumer Tissue Private Label Europe business amounted to approximately SEK 9.8bn in 2022, corresponding to about 15% of net sales in the Consumer Tissue category. The business encompasses seven production facilities in Belgium, France, Germany and Italy with approximately 1,900 employees. Other operations in Consumer Tissue, which include own brands and strategic collaborations to develop retailer brands, are a prioritized business focusing on innovation, brands and sustainability.

    NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 14:45 CET on April 26, 2023. 

    Karl Stoltz, Media Relations Director, +46 709 426 338

    Essity Press release
    Back to press releases

    Share this

    Essity logo
    Company Careers Brands Breaking Barriers Contact Us
    Privacy Policy Cookies Terms and Conditions

    Tel +46 8-788 51 00

    © Essity Aktiebolag (publ). Box 200, SE-101 23, Stockholm, Sweden